Immunogenetic aspects of preeclampsia. 1987

P F Bolis, and M Martinetti Bianchi, and A La Fianza, and M Franchi, and M Cuccia Belvedere

The etiology of preeclampsia (PE) is so far unknown; nevertheless both clinical and experimental findings suggest the possibility that immunogenetic factors operate in this disorder. In order to verify the role of immunogenetic factors in PE, a selected group of women (n = 26) affected with PE was chosen and HLA (human leucocytes A) frequency distribution, HLA antigens sharing between couples, homozygosity, incidence of HLA phenotypes and maternal antibody production were investigated. Neither significant differences in HLA frequencies nor homozygosity condition in preeclamptic and/or in the partners have been noted. HLA typing of the couples under study however demonstrates a very high antigen sharing between partners if compared with the sharing found in couples with normal reproductive performance. In 46% of PE women it was possible to demonstrate the presence of cytotoxic antibodies against surface structures of partner lymphocytes. The role of the MHC (major histocompatibility complex) in fetal survival and outcome is discussed.

UI MeSH Term Description Entries
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011225 Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. Toxemias, Pregnancy,EPH Complex,EPH Gestosis,EPH Toxemias,Edema-Proteinuria-Hypertension Gestosis,Gestosis, EPH,Hypertension-Edema-Proteinuria Gestosis,Preeclampsia,Preeclampsia Eclampsia 1,Pregnancy Toxemias,Proteinuria-Edema-Hypertension Gestosis,Toxemia Of Pregnancy,1, Preeclampsia Eclampsia,1s, Preeclampsia Eclampsia,EPH Toxemia,Eclampsia 1, Preeclampsia,Eclampsia 1s, Preeclampsia,Edema Proteinuria Hypertension Gestosis,Gestosis, Edema-Proteinuria-Hypertension,Gestosis, Hypertension-Edema-Proteinuria,Gestosis, Proteinuria-Edema-Hypertension,Hypertension Edema Proteinuria Gestosis,Of Pregnancies, Toxemia,Of Pregnancy, Toxemia,Pre Eclampsia,Preeclampsia Eclampsia 1s,Pregnancies, Toxemia Of,Pregnancy Toxemia,Pregnancy, Toxemia Of,Proteinuria Edema Hypertension Gestosis,Toxemia Of Pregnancies,Toxemia, EPH,Toxemia, Pregnancy,Toxemias, EPH
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006681 HLA-D Antigens Human immune-response or Class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology. Antigens, HLA-D,Class II Human Antigens,HLA-Dw Antigens,Human Class II Antigens,Ia-Like Antigens, Human,Immune Response-Associated Antigens, Human,Immune-Associated Antigens, Human,Immune-Response Antigens, Human,HLA-D,HLA-Dw,Immune Response Associated Antigens, Human,Antigens, HLA D,Antigens, HLA-Dw,Antigens, Human Ia-Like,Antigens, Human Immune-Associated,Antigens, Human Immune-Response,HLA D Antigens,HLA Dw Antigens,Human Ia-Like Antigens,Human Immune-Associated Antigens,Human Immune-Response Antigens,Ia Like Antigens, Human,Immune Associated Antigens, Human,Immune Response Antigens, Human
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes

Related Publications

P F Bolis, and M Martinetti Bianchi, and A La Fianza, and M Franchi, and M Cuccia Belvedere
January 2018, Frontiers in immunology,
P F Bolis, and M Martinetti Bianchi, and A La Fianza, and M Franchi, and M Cuccia Belvedere
November 1976, JAMA,
P F Bolis, and M Martinetti Bianchi, and A La Fianza, and M Franchi, and M Cuccia Belvedere
January 1976, Advances in experimental medicine and biology,
P F Bolis, and M Martinetti Bianchi, and A La Fianza, and M Franchi, and M Cuccia Belvedere
December 1971, Recenti progressi in medicina,
P F Bolis, and M Martinetti Bianchi, and A La Fianza, and M Franchi, and M Cuccia Belvedere
August 1987, Journal of neurogenetics,
P F Bolis, and M Martinetti Bianchi, and A La Fianza, and M Franchi, and M Cuccia Belvedere
January 1983, Zeitschrift fur arztliche Fortbildung,
P F Bolis, and M Martinetti Bianchi, and A La Fianza, and M Franchi, and M Cuccia Belvedere
February 1998, Doklady Akademii nauk,
P F Bolis, and M Martinetti Bianchi, and A La Fianza, and M Franchi, and M Cuccia Belvedere
September 2009, Investigacion clinica,
P F Bolis, and M Martinetti Bianchi, and A La Fianza, and M Franchi, and M Cuccia Belvedere
February 2024, Genes,
P F Bolis, and M Martinetti Bianchi, and A La Fianza, and M Franchi, and M Cuccia Belvedere
February 1987, Transplantation proceedings,
Copied contents to your clipboard!